News
Analysts still expect a solid second quarter from Alphabet. But others say AI technology now poses a deeper threat to ...
Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.
The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results